美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Faeth Therapeutics

35.37

-3.7200-9.52%

盤後：35.880.5100+1.44%19:53 EDT

成交量：20.94萬

成交額：766.62萬

市值：9.12億

市盈率：-0.25

高：39.89

開：38.75

低：34.88

收：39.09

52周最高：42.14

52周最低：7.45

股本：2,577.88萬

流通股本：81.17萬

量比：0.68

換手率：25.80%

股息：- -

股息率：- -

每股收益(TTM):-141.6499

每股收益(LYR):-16.7239

淨資產收益率：-195.26%

總資產收益率：-20.79%

市淨率：5.27

市盈率(LYR):-2.11

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

FDA授予抗癌藥物快速通道資格後，Faeth Therapeutics股價上漲

Faeth Therapeutics：晚期子宮內膜癌2期試驗頂線數據預計2026年底公布

美國研究綜述-美國鐵塔公司、H.B.富勒公司、TD Synnex

Sensei Biotherapeutics：Piktor治療HR+/HER2-晚期乳腺癌的1B/2期中期數據預計2027年公布

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/FTH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":35.37,"timestamp":1789502400000,"preClose":39.09,"halted":0,"volume":209394,"hourTrading":{"tag":"盘后","latestPrice":35.88,"preClose":35.37,"latestTime":"19:53 EDT","volume":358,"amount":12833.5401,"timestamp":1789516430954,"change":0.51,"changeRate":0.014419,"amplitude":0.014419},"delay":0,"changeRate":-0.09516500383729869,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"未開盤","change":-3.72,"latestTime":"09-15 16:00:00 EDT","open":38.75,"high":39.89,"low":34.88,"amount":7666233.875244,"amplitude":0.128166,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-141.6499,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":39.09,"postHourTrading":{"tag":"盘后","latestPrice":35.88,"preClose":35.37,"latestTime":"19:53 EDT","volume":358,"amount":12833.5401,"timestamp":1789516430954,"change":0.51,"changeRate":0.014419,"amplitude":0.014419},"volumeRatio":0.675028},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":0.675028,"shares":25778800,"dividePrice":0,"high":39.89,"amplitude":0.128166,"preClose":39.09,"low":34.88,"week52Low":7.45,"pbRate":"5.27","week52High":42.1431,"institutionHeld":0,"latestPrice":35.37,"eps":-141.6499,"divideRate":0,"volume":209394,"delay":0,"ttmEps":-141.6499,"open":38.75,"prevYearClose":10.67,"prevWeekClose":37.44,"prevMonthClose":32.77,"prevQuarterClose":25,"fiveDayClose":39.2,"twentyDayClose":32.77,"sixtyDayClose":17.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-09-14","current":-0.2497,"percent":0.101695,"low":-5.292894,"twenty":-4.561008,"median":-3.985108,"eighty":-3.360395,"high":-0.105707,"avg":-3.827199,"sd":1.140745,"marketCap":967465512},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-11","current":-5.154129,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"marketCap":1007776575},{"date":"2026-09-14","current":-4.947964,"twenty":-4.561008,"median":-3.985108,"eighty":-3.360395,"marketCap":967465512}],"updateTime":1789528486797},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660448760","title":"FDA授予抗癌藥物快速通道資格後，Faeth Therapeutics股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448760","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448760?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:19","pubTimestamp":1786969153,"startTime":"0","endTime":"0","summary":"BUZZ-FDA授予抗癌药物快速通道资格后，Faeth Therapeutics股价上涨8月17日-** 抗癌药物开发商 Faeth Therapeutics（FTH.O）的股价在盘前交易中上涨 2%，至 33 美元** 该公司表示，美国食品药品监督管理局（FDA）已授予其实验性双药疗法PIKTOR（联合化疗）快速通道资格，该疗法适用于部分晚期或复发性子宫内膜癌患者，子宫内膜癌是一种起源于子宫内膜","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0SZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137671951","title":"Faeth Therapeutics：晚期子宮內膜癌2期試驗頂線數據預計2026年底公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1137671951","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137671951?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 19:33","pubTimestamp":1786966420,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics宣布，其针对晚期子宫内膜癌的2期临床试验顶线数据，预计将于2026年底揭晓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646343783","title":"美國研究綜述-美國鐵塔公司、H.B.富勒公司、TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646343783","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646343783?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 15:07","pubTimestamp":1782457653,"startTime":"0","endTime":"0","summary":"美国研究综述-美国铁塔公司、H.B.富勒公司、TD Synnex路透6月26日-周五，华尔街的证券分析师们调整了多家在美国上市公司的评级和目标股价，其中包括美国铁塔公司、H.B.富勒公司和TD Synnex。重点摘要* 美国铁塔公司AMT.N：加拿大皇家银行将其评级从“行业表现”上调至“跑赢大盘”* H.B.富勒公司 FUL.N：摩根大通将评级从“中性”上调至“超配”* TD SynnexSNX.N：RBC将目标价从315美元上调至340美元以下是路透周五报导的针对美国公司的研究动向摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4T42Y0EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU0823417737.USD","LU2023250504.SGD","IE000MB6IJN5.SGD","IE00BSNM7G36.USD","SG9999001176.SGD","LU1066051498.USD","LU0444973449.USD","MUU","BK4567","LU1674673428.USD","LU1868836914.USD","BK4605","SG9999002224.SGD","IE00BQXX3D17.EUR","INR","LU1057294990.SGD","LU2250418816.HKD","ON","IE000BZT7R73.USD","IE00BFMHRM44.USD","LU1046421795.USD","LU1974910355.USD","LU2756315318.SGD","LU0345769631.USD","LU0689626769.HKD","LU0234570918.USD","LU0757428866.USD","LU1935042991.SGD","IE00BJT1NW94.SGD","LU0964807845.USD","LMT","LU1023059063.AUD","ESS","LU0868494708.USD","IE00BQXX3F31.USD","LU0082616367.USD","LU0320765646.SGD","MRNX","LU2592432038.USD","LU0231203729.USD","LU1861215975.USD","LU2347655156.SGD","LU2505996681.GBP","LU1162221912.USD","BK4532","LU1868837300.USD","LU0289960550.SGD","LU1823568750.SGD","LU0345769128.USD","LU2417539215.USD","LU0354030511.USD","BK4554","LU1061106388.HKD","BK4213","BK4588","LU2133065610.SGD","LU1221951129.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1035775433.USD","LU1244550577.SGD","LU0056508442.USD","IE0034235303.USD","SYNA","LU1778281490.HKD","BK4501","LU2506951958.HKD","SNX","LU1551013342.USD","LU2129689514.USD","LU2896262040.SGD","LU0109392836.USD","PCTY","LU1914381329.SGD","LU2403377893.USD","LU1805238398.USD","IE000SO60NU8.SGD","LU0476273544.USD","LU2290526834.HKD","LU0127658192.USD","LU2458330243.SGD","LU1166156734.SGD","LU2213496289.HKD","LU2458330169.SGD","BK4141","LMTS","LU0553294199.USD","LU1066051225.USD","LU2089984988.USD","LU2360107325.USD","LU1815336091.USD","BK4177","LU2360106780.USD","IE00BZ1G4Q59.USD","LU0444971666.USD","LU0689472784.USD","LU2357627491.SGD","LU0642271901.SGD","SG9999013999.USD","GB00BDT5M118.USD","LU2413666699.HKD","LU0061475181.USD","LU0889566641.SGD","BK4187","JNJ","LU0432979614.USD","IE00B2B36J28.USD","LU0640476718.USD","LU1032955483.USD","BK4219","LU0011850046.USD","BK4548","LU1003077747.HKD","LU2471134523.USD","LU1228905037.USD","LU0347712357.USD","LU0070217475.USD","LU0256331488.USD","LU2468319806.SGD","LU2430703095.HKD","LU2931357623.SGD","BK4527","LU0985320562.USD","BK4551","LU0345770308.USD","LU2298322129.HKD","BK4215","LU2211815571.USD","LU1430594728.SGD","BK4084","LU0072462343.USD","IE00BFXG1179.USD","LU0154245756.USD","LU0795875169.SGD","LU2602419157.SGD","LU1894683264.USD","LU1929549753.HKD","MULL","LU0287143357.SGD","BK4518","SG9999001424.SGD","LU1868836757.USD","LU2543165471.USD","LU1196500208.SGD","IE000M9KFDE8.USD","BK4592","LU0943347566.SGD","MRNY","IE00BBT3K403.USD","IE0000B7K699.USD","LU2236285917.USD","LU1244550221.USD","AR","OVV","LU0124384867.USD","LU1228905540.USD","LU1048596156.SGD","LU1585245621.USD","LU1815336760.USD","AVXX","LU2506951875.HKD","IE00BVYPNW00.USD","LU2487616109.SGD","SG9999002232.USD","LU1983260115.SGD","IE00BKVL7J92.USD","LU2129689431.USD","BK4209","MUD","LU1244550494.USD","IE00B1BXHZ80.USD","LU1721428933.USD","IE00BFTCPJ56.SGD","IE00BLSP4239.USD","LU2129689605.HKD","IE0009356076.USD","LU2023250843.SGD","LU0006061336.USD","AMT","LU2028103732.USD","IE00B7SZLL34.SGD","LU0079474960.USD","BK4585","LU0702159343.USD","SG9999001440.SGD","LU1121112475.USD","SG9999000418.SGD","BK4533","BK4579","LU2106854487.HKD","LU1861214812.USD","LU0820561818.USD","LU0792757196.USD","LU2430703178.SGD","BK4134","LU0820561909.HKD","LU1043141396.HKD","LU1366333091.USD","LU1323610961.USD","BK4139","IE00BK4W5L77.USD","LU0175139822.USD","BK4553","LU1551013425.SGD","IE0002141913.USD","LU0097036916.USD","LU0882574055.USD","LU0210536198.USD","LU2271345857.HKD","LU2089283258.USD","LU1059921491.USD","BK4597","IE00B3PB1722.GBP","LU2023250330.USD","BK4023","LU0114720955.EUR","LU2111349929.HKD","LU0124676726.USD","PEP","BK4550","AVAV","MU","LU2456880835.USD","BK4581","LU0820562030.AUD","LU1316542783.SGD","IE00BN8TJ469.HKD","LU1732799900.SGD","LU0823417653.USD","LU1839511570.USD","BK4109","LU2286300806.USD","LU2756315664.SGD","IE0009355771.USD","LU1803068979.SGD","IE000F7OJYX1.SGD","LU0157215616.USD","BK4604","LU0466842654.USD","KWR","LU0950375773.USD","LU2054465674.USD","LU0426412945.USD","LU1978683503.SGD","LU0795875086.SGD","IE00BK4W5M84.HKD","LU1261432733.SGD","BK4504","BK4559","LU1066051811.HKD","BK4575","IE00BGHQF631.EUR","LU0154245673.USD","BK4130","LU0203345920.USD","LU2087621335.USD","LU0545562505.USD","LU0122379950.USD","LU2048586759.USD","LU2413666426.HKD","LU0158827781.USD","LU0787776722.HKD","BK4512","LU1221951046.USD","LU0234572021.USD","MRNA","LU0081259029.USD","LU1989773731.SGD","LU0957808578.USD","LU0096362180.USD","LU2750360997.AUD","BK4566","LU1854103824.USD","BK4564","LU0868494617.USD","LU0158827948.USD","IE00B4R5TH58.HKD","LU1815333072.USD","LU0354030438.USD","LU1894683348.USD","LU1506573853.SGD","LU0274383776.USD","LU0738911758.USD","LU0545039389.USD","IE00BDGV0183.EUR","LU0238689110.USD","LU0061474960.USD","IE00B42XCP33.USD","LU1074936037.SGD","BK4534","LU1280957306.USD","LU1496350502.SGD","LU2505996509.AUD","SGXZ57979304.SGD","LU2471134952.CNY","LU2471134879.HKD","04336","LU0957791311.USD","IE00BVYPNV92.GBP","LMTL","IE000WAW04H5.SGD","LU0426417589.USD","LU1267930656.SGD","LU2471134796.USD","IE00B5949003.HKD","LU0053666078.USD","LU0719512351.SGD","LU2430703251.USD","LU0197229882.USD","LU0198837287.USD","BK4140","IE00B19Z3B42.SGD","BK4147","LU0702159699.USD","LU1720051017.SGD","LU2112291526.USD","LU0949170772.SGD","BK4516","IE0002270589.USD","LU1069344957.HKD","LU1732800096.USD","LU0821914370.USD","LU1861220033.SGD","LU2357305700.SGD","LU1032466523.USD","LU0098860793.USD","IE00B19Z3581.USD","IE0001KFT4U8.USD","IE00B3T34201.USD","LU0536402901.SGD","LU0724618433.USD","SG9999001176.USD","LU0348723411.USD","LU0942090050.USD","LU0661504455.SGD","LU0154236417.USD","LU0289739699.SGD","LU2023251221.USD","BK4519","BK4603","LU0345770993.USD","LU2089284900.SGD","IE00BQXX3C00.GBP","LU2506952170.USD","LU0994945656.USD","LU2360107168.USD","LU1868836591.USD","LU1720051108.HKD","DRI","LU1868837136.USD","LU2506952097.USD","LU0708995666.HKD","AMAT","LU1145028129.USD","LU1861219969.SGD","IE0034390439.USD","LU1983299246.USD","LU1718418525.SGD","LU0889565833.HKD","LU1674673691.USD","BK4007","CTSH","BK4568","LU0210528500.USD","KYMR","LU1267930813.SGD","LU1852331112.SGD","LU1917777945.USD","BK4543","IE00BD6J9T35.USD","LU1066053197.SGD","LU1642822529.SGD","LU1043141123.HKD","LU0859254822.USD","LU2750360641.GBP","IE00BZ199S13.USD","LU1548497426.USD","LU1048588211.SGD","LU1153585028.USD","LU2089985449.USD","LU1629891620.HKD","FUL","FTH","IE00BLSP4452.SGD","IE00B19Z6F94.USD","LU1854104046.USD","LU0912757837.SGD","LU0096364046.USD","LU0203347892.USD","LU1989763005.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155638133","title":"Sensei Biotherapeutics：Piktor治療HR+/HER2-晚期乳腺癌的1B/2期中期數據預計2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155638133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155638133?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选疗法Piktor针对HR阳性、HER2阴性晚期乳腺癌的1B/2期临床试验中期数据，预计将于2027年获得。该数据将提供关于疗法安全性及初步疗效的关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNSE","FTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FTH\",params:#limit:6,delay:false,,,undefined,":[]}}